Evidence map›Paper›PMID 33964221›Full record

ArticleLancet (London, England)2021

COVID-19 vaccine impact in Israel and a way out of the pandemic.

Eyal Leshem, Annelies Wilder-Smith

Abstract readComment
In one paragraph

Article in Lancet (London, England), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Graft rejection in component keratoplasty.Indian journal of ophthalmology · 2023
    Review
  11. A Game-Theory-Based Approach to Promoting Health Policy among Minorities.International journal of environmental research and public health · 2023
    Article
  12. Post-acute sequelae of COVID-19 infection.Preventive medicine reports · 2023
    Article
  13. Article
  14. Article
  15. Article
  16. Observational
  17. I have decided about my COVID-19 vaccine, what about my child?Human vaccines & immunotherapeutics · 2022
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Eyal LeshemThe Chaim Sheba Medical Centre, RamatGan 52621, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. Electronic address: eyal.leshem@sheba.health.gov.il.
Annelies Wilder-SmithDepartment of Disease Control, London School of Hygiene & Tropical Medicine, London, UK; Heidelberg Global Health Institute, University of Heidelberg, Heidelberg, Germany.

Funding

Medical Research CouncilWellcome Trust
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19VaccinesBNT162 VaccineCOVID-19 VaccinesHospitalizationHumansImmunization ProgramsIsraelPandemicsRNA, MessengerSARS-CoV-2BNT162 VaccineCOVID-19 VaccinesRNA, MessengerVaccines

Identifiers

PMID33964221
PMCPMC8099312

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.